LIPOCINE INC. Cash and Cash Equivalents, Fair Value Disclosure
LIPOCINE INC. (LPCN) had Cash and Cash Equivalents, Fair Value Disclosure of $0 as of 2014-12-31, per its 10-K filed 2015-03-11.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures
us-gaap:CashAndCashEquivalentsFairValueDisclosure · last filed 2015-03-11
- 2014-12-31: Cash and Cash Equivalents, Fair Value Disclosure $0.00.
- 2013-12-31: Cash and Cash Equivalents, Fair Value Disclosure $1.93M.
- 2013-09-30: Cash and Cash Equivalents, Fair Value Disclosure $1.93M.
- 2012-12-31: Cash and Cash Equivalents, Fair Value Disclosure $2.69M.
| Period end | Cash and Cash Equivalents, Fair Value Disclosure |
|---|---|
| 2014-12-31 | $0.00 10-K · filed 2015-03-11 |
| 2013-12-31 | $1.93M 10-K · filed 2015-03-11 |
| 2013-09-30 | $1.93M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $2.69M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |